SCHEMBL20054469

SCHEMBL20054469

CC(O)(C(=O)N[C@H](c1nc(-c2ccc(-c3ccc(-c4c[nH]c([C@@H](NC(=O)C(C)(O)c5ccccc5)C(C)(C)C)n4)cc3)cc2)c[nH]1)C(C)(C)C)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
AR P10275 1/20 0.35
ADORA1 P30542 2/20 0.34
CASP1 P29466 1/20 0.34
CASP3 P42574 1/20 0.34
CASP7 P55210 1/20 0.34
CASP8 Q14790 1/20 0.34
PDE2A O00408 3/20 0.32
ROCK2 O75116 1/20 0.32
ROCK1 Q13464 1/20 0.32
EIF2S1 P05198 2/20 0.32
EIF2AK3 Q9NZJ5 2/20 0.32
SGK1 O00141 1/20 0.32
MME P08473 2/20 0.32
ACE P12821 2/20 0.32
TACR3 P29371 1/20 0.32
ACE2 Q9BYF1 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15114299 1.00 CNR1 (0.35) CNR1CNR2ARADORA1CASP1
SCHEMBL15114300 1.00 CNR1 (0.35) CNR1CNR2ARADORA1CASP1
SCHEMBL20054354 1.00 CNR1 (0.35) CNR1CNR2ARADORA1CASP1
SCHEMBL20054353 1.00 CNR1 (0.35) CNR1CNR2ARADORA1CASP1
SCHEMBL20054451 0.83 ADORA1 (0.32) CNR1CNR2ADORA1
SCHEMBL15114308 0.83 ADORA1 (0.32) CNR1CNR2ADORA1
SCHEMBL19388431 0.83 FAAH (0.33) CNR1CNR2ADORA1PDE2AROCK1
SCHEMBL15113745 0.83 FAAH (0.33) CNR1CNR2ADORA1PDE2AROCK1
SCHEMBL15113728 0.83 PRCP (0.34) CNR1CNR2ADORA1
SCHEMBL20054322 0.83 PRCP (0.34) CNR1CNR2ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 EP disclosed
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed